JULIET GATOBU: Open Payments
NPI 1245711050 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,039 in 70 payments from 7 companies in 2025. Trend: 2023 $1,806 · 2024 $2,320 · 2025 $2,039
Food & beverage: $1,850Education: $189
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 26 | $825 |
| Alkermes, Inc. | 24 | $623 |
| Janssen Scientific Affairs, LLC | 2 | $282 |
| Neurocrine BioSciences, Inc. | 11 | $165 |
| Otsuka America Pharmaceutical, Inc. | 3 | $71 |
| E.R. Squibb & Sons, L.L.C. | 3 | $65 |
| Janssen Pharmaceuticals, Inc | 1 | $9 |
Products named: UZEDY, ARISTADA, INVEGA SUSTENNA, LYBALVI, INGREZZA, AUSTEDO XR, REXULTI, COBENFY.
Industry payments across TX — which companies pay providers there.
